Comparision of simulect and thymoglobulin induction in an early steroid cessation protocol in renal transplant recipients.

被引：0
|
作者：
Peddi, V. Ram [1 ]
Ueda, Kimi [1 ]
Bry, William [1 ]
Bohannon, Lawrence [1 ]
Silkensen, John [1 ]
Warvarix, Vasyl [1 ]
Tsien, Isabelle [1 ]
Walsh, Brian [1 ]
Arsalane, Paul [1 ]
Katznelson, Steven [1 ]
机构：
[1] Calif Pacific Med Ctr, Geraldine Brush Canc Res Inst, San Francisco, CA 94115 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1190
引用
收藏
页码：453 / 453
页数：1
相关论文
共 50 条
  • [1] Early results in the use of thymoglobulin and simulect as induction therapy in high-risk renal transplant recipients.
    Hanaway, MJ
    Knechlte, SJ
    Pirsch, JD
    Odorico, JS
    D'Alessandro, AM
    Kalayoglu, M
    Becker, YT
    Chin, LT
    Cooper, JT
    Sollinger, HW
    [J]. TRANSPLANTATION, 2000, 69 (08) : S160 - S160
  • [2] A Pharmacoeconomic Analysis of Alemtuzumab Versus Thymoglobulin Induction in Renal Transplant Recipients.
    Tseng, Christine Y.
    Truscott, Christie B.
    Zavala, Edward
    Feurer, Irene
    Shaffer, David
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 370 - 370
  • [3] Safety of thymoglobulin induction in HCV liver transplant recipients.
    Bajjoka, Iman
    Hsaiky, Lama
    Brown, Kimberly
    Abouljoud, Marwan
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 164 - 164
  • [4] Perioperative thymoglobulin induction in paediatric heart transplant recipients.
    Dipchand, A. I.
    Allain-Rooney, T.
    Babu, A.
    Pollock-Barziv, S. M.
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 : 53 - 53
  • [5] Experience with Thymoglobulin® induction therapy in pancreas transplant recipients.
    Wiland, AM
    Fink, JC
    Philosophe, B
    Farney, AC
    Schweitzer, EJ
    Colonna, JO
    Weir, MR
    Bartlett, ST
    [J]. TRANSPLANTATION, 2000, 69 (08) : S408 - S408
  • [6] Thymoglobulin versus simulect induction in hepatitis C positive kidney transplant recipients
    Marfo, Kwaku
    Olaywi, Manhal
    Chapochnick, Javier
    Kinkhabwala, Milan
    Greenstein, Stuart
    Kayler, Liise
    Lubetzky, Michele
    Boccardo, GraciellaDe
    Akalin, Enver
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E247 - E248
  • [7] Thymoglobulin is less expensive and as effective as ATGam for induction therapy in pediatric renal transplant recipients.
    Durand, BJ
    Matas, A
    Ingulli, E
    [J]. TRANSPLANTATION, 2000, 69 (08) : S306 - S306
  • [8] Clinical experience with repeated courses of thymoglobulin for induction and for treatment of rejection in renal transplant recipients.
    Lo, A
    Olson, B
    Gaber, LW
    Gaber, AO
    [J]. PHARMACOTHERAPY, 2003, 23 (03): : 413 - 413
  • [9] A Multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus
    Woodle, ES
    Vincenti, F
    Lorber, MI
    Gritsch, HA
    Hricik, D
    Washburn, K
    Matas, AJ
    Gallichio, M
    Neylan, J
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (01) : 157 - 166
  • [10] Delayed cyclosporine administration following simulect induction does not increase acute rejection in renal transplant recipients.
    Pelletier, RP
    Bumgardner, GL
    Davies, EA
    Elkhammas, EA
    Henry, ML
    Ferguson, RM
    [J]. TRANSPLANTATION, 2000, 69 (08) : S158 - S159
12345